Background: Placenta previa is a localization of placenta in the lower uterine segment, near or over the internal os. Multigravida is one of the risk factors of placenta previa. The aim of study is to look for current frequency of placenta previa in multigravida, so that further improvement in diagnosis and treatment modalities can be made in order to decrease the morbidity & mortality related to it in this group.
Introduction
Placenta previa is in fact localization of placenta in the lower uterine segment, over or near the internal os, which is not a normal site of placental attachment 1 . It undertakes clinical significance due to its adherent risk of maternal and perinatal morbidity and mortality. The frequency of placenta previa is reported as 3-5 per 1000 pregnancies 2 and it is globally and statistically mounting due to swelling risk factors 3 .
The predisposition for occurrence of placenta previa is observed more in past era chiefly because of higher caesarean section rate and unconventionally late maternal age at conception 4 . Even though origination of placenta previa stagnantly remains ambiguous, but multiple threatening elements can reveal its happening embracing Caesarean Section, high parity, increasing age and previous abortions 5 . Life style of women also plays its role, likewise if mother is having history of smoking and cocaine during pregnancy ,these too have been seen escalating the possibility of placenta previa 6 .
Observation is that, there occurs a defect in endometrial lining causing its atrophy due to previous scarring or inflammation in the endometrium, ensuing in unusually low implantation of the placenta at the level of internal uterine os with ample blood supply 7 . There are 4 grades of placenta previa. All the grades of placenta previa can cause painless vaginal bleeding during second or third trimester at any time, that further may result in postpartum haeorrhage, air embolism and ascending infection compromising maternal status and maternal mortality, fetal growth retardation, congenital malformation, fetal anemia, malpresentation and un expected fetal death 8, 9 . Multiparty has been considered as an important risk factor for placenta previa. These women are prone to have sixteen times more chances of placenta previa as compared to nullipara 10 . Maternal and fetal mortality can be reduced by identifying the high risk patients and educating them for care about next pregnancy 11 . For the diagnosis of placenta previa, although trans vaginal ultrasound is gold standard but transabdominal is also having75% accuracy in identification 12 . The overall prevalence of placenta previa in setup like ours is 3.5%.
Though lots of studies have been done on placenta previa, but studies specifically on placenta previa in multigravida are scarce in Bangladesh, as well as internationally. Aim of our study is to look for current frequency of placenta previa in multigravida in order to have further improvement in the diagnosis and treatment modalities, hence to decrease the morbidity & mortality related to it.
Subjects and Method
This cross sectional study was conducted at the department of Gynecology and Obstetrics, , Rajshahi Medical College Hospital during the period from December 2014 to June 2015 after taking formal approval from institutional ethical committee.The sample size obtained with nonprobability purposive technique calculated by using World Health Organization sample size determination software with 95% confidence interval, 2.5% level of precision considering the prevalence of placenta previa as 3.5%.11 Accordingly we enrolled 208 patients in this study, after fulfilling following selection criteria as follows
Inclusion Criteria
• All pregnant women of 25-35 years of age in their second or more pregnancy.
• Gestational age ≥ 34 weeks.(ultrasound based)
Exclusion Criteria • Previous history of cesarean section (CS). • Past history of dilatation and curettage (D & C).
• History of cervical cone biopsy.
• History of myomectomy or other any pelvic surgery.
• Multifetal pregnancy
The data was collected after explaining the study protocol and informed written consent. This was an observational study so no women denied. Confidentiality regarding patients' medical and nonmedical details was maintained. All possible effect modifying variable as parity, maternal age, gestation age, were noted.
All pregnant women underwent trans-abdominal ultrasound. Trans-vaginal ultrasound experts are available at our institute but patients usually refuse due to social constraints so we did not offer them. The presence or absence of placenta previa was reported by an experienced sonologist with 8 years' experience in relevant field. All the collected data was transferred to predesigned Performa and analysis of data done through SPSS version 12.
Results
A total of 208 patients were enrolled in this study during six months period. The age assortment of women considered was from 25 to 35 years. Equal number of patients was found to be in group of 25-30 years 104 women (50%) and same figure of 104 in 31-35 year as well. Therefore their mean age was 30.1±5.6 years. We had included patients more than 34 weeks, so there were majority of patients (156/208) at 38 -39 weeks of gestation with mean gestational age was 38±1.4 weeks. The important figure of exploration was parity Thus 52% patient had parity beyond 5 and mean parity was 4.02±1.2 ranging from 1 to 5.
The number of multigravida women who had placenta previa was 13 and that made 6.3% of frequency at our setup. The type IV placenta previa was the most common type; further distribution shown in figure 1 Stratified analysis of placenta previa based on age, body mass index, is summarized in table I Among 156 patients having gestational age 38-39 weeks, 10 (6.4%) had placenta previa as compared to 1 (4.8%) woman in the group of patients with gestational age 34-35 weeks.
Of 109 patients of parity >5, we had 11 women with (10.1%) making 84% of total (11/13) patients with placenta previa compared to 1 woman (6.7%) in group of primiparity. Break up is also shown in table II. 
Discussion
Hemorrhage in pregnancy is still the commonest cause of maternal deaths in the parts of world with low incomes 13 . Placeta previa in symptomatic women may cause some times furious bleeding risking both mother and baby.
Advancing maternal age is a recognized hazardous issue for abnormally situated placenta. It has been established that women at or beyond 35 years of age are vulnerable population to have placenta previa 14 . The pathophysiology, how advanced maternal age impedes normal placental expansion is not well agreed. The potential description is, that the proportion of sclerotic changes on intramyometrial arteries escalates with increasing age, thus plummeting blood supply to placenta 15 .
In our study also, we have observed that higher maternal age is a risk factor of placenta previa (PP). We found that in women of 31-35 years of age, the frequency of placenta previa was 9.6% compared to 25-30 years of age, where the frequency of placenta previa was 2.9%. We found in our results, the frequency of placenta previa in patients with body mass index (BMI) >30 was 10.3% in comparison to 4.8% patients with body mass index <20 16, 17 . However this may not stand statistically significant. Many studies are supporting obesity complicating pregnancy and one of those complications is placenta previa particularly seen in one study where obesity and morbid obesity were associated with an increased risk for placenta previa 18 .
Presentation of women with placenta previa may be symptomatic or it may be accidental finding during routine ultrasound at different gestational periods. Analysis of our findings was in patients with gestational age 38-39 weeks, the frequency of placenta previa was 6.4% in comparison to 4.8% in patients having gestational age 34-35 weeks. Nevertheless it is likewise conclusion of studies done by other authors as well 19 .
Multiparty has been linked as a well-known independent risk factor for developing placenta previa, thus frequency of placenta previa then increases as the parity increases remarkably 20 . It is recognized since years in the literature available globally that, women with high parity are at the highest risk of developing placenta previa 21 . women whose parity is greater than four, thus demonstrating a well-known association. Similarly we found in our setup, that patients of parity >5 the frequency of placenta previa(PP) was 10.1% compared to 6.7% in primiparous. It makes 84% of total (11/13) women having placenta previa (PP). The difference of proportion of said condition between two groups is quite significant. These observations are also instituted in studies conducted in national and international levels as well, where reportedly 60% of their patients of placenta previa were multiparous 22 . Another author has similar findings in her study sharing same social scenario of highest turnover of those women who never practice contraception and end up in complicated pregnancy with placenta previa.
In one other study 23 , it was concluded that the women having less parity halves the chances of Placenta Previa than those with or higher than 3 and identical with findings of our study.
Conclusion
The finding of this study highlights that apart from other complications in multiparous women, placenta previa also poses a great threat to mother as an independent risk. Antenatal diagnosis of Placenta previa may help in planning mode of delivery and saving fetomaternal lives. Being part of low resource setting, we must emphasize on capacity building to have emergency obstetric services available to mothers everywhere.
